Clinical Effects of Frontal Behavioral Impairment: Cortical Thickness and Cognitive Decline in Individuals with Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment
Restricted accessResearch articleFirst published online May 7, 2019
Clinical Effects of Frontal Behavioral Impairment: Cortical Thickness and Cognitive Decline in Individuals with Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment
Frontal behavioral impairment (FrBI) is commonly observed in various degenerative diseases and refers to various behavioral symptoms.
Objective:
We investigated the effects of the presence of FrBI on cortical thickness, and the longitudinal neuropsychological changes in people in the predementia stage.
Methods:
A total of 794 individuals completed neuropsychological tests and the Frontal Behavioral Inventory (FBI) Questionnaire, and underwent magnetic resonance (MR) scanning. Participants were analyzed and grouped into non-FrBI (FBI = 0) or FrBI (FBI≥1). Cortical thickness was measured on MR images using a surface-based method.
Results:
In total, 281 people with subjective cognitive decline (SCD) and 513 with amnestic mild cognitive impairment (aMCI) were assessed for FrBI. Relative to people without FrBI, those with FrBI presented reduced cortical thickness in the frontal, anterior temporal and lateral parietal regions (p < 0.05, FDR corrected). People with FrBI developed Alzheimer’s disease, rather than behavioral variant frontotemporal dementia, as observed over seven years. Mixed effects models reported that people with FrBI have greater cognitive decline than those with non-FrBI in multiple domains, including language, memory, and executive functions (p < 0.05, FDR corrected). Furthermore, while negative FrBI symptoms (e.g., deficit behaviors) were associated with greater declines in multiple domains, positive FrBI symptoms (e.g., disinhibition symptoms) were related to declines in visuospatial function and verbal memory. Finally, the occurrence of both types of symptoms correlated with multi-domain cognitive decline.
Conclusions:
FrBI predicted worse clinical outcomes, including reduced cortical thickness and cognitive decline, which are not necessarily specific to frontal dysfunction.
RosenHJ, Gorno-TempiniML, GoldmanWP, PerryRJ, SchuffN, WeinerM, FeiwellR, KramerJH, MillerBL (2002) Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology58, 198–208.
3.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
4.
ReisbergB, FerrisSH, de LeonMJ, CrookT (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry139, 1136–1139.
5.
FlickerC, FerrisSH, ReisbergB (1991) Mild cognitive impairment in the elderly: Predictors of dementia. Neurology41, 1006–1009.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
9.
JessenF, WieseB, BachmannC, Eifflaender-GorferS, HallerF, KolschH, LuckT, MoschE, van den BusscheH, WagnerM, WollnyA, ZimmermannT, PentzekM, Riedel-HellerSG, RombergHP, WeyererS, KaduszkiewiczH, MaierW, BickelH; German Study on Aging, Cognition and Dementia in Primary Care Patients Study Group (2010) Prediction of dementia by subjective memory impairment: Effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry67, 414–422.
10.
KerteszA, DavidsonW, FoxH (1997) Frontal behavioral inventory: Diagnostic criteria for frontal lobe dementia. Can J Neurol Sci24, 29–36.
11.
Van der MusseleS, MarienP, SaerensJ, SomersN, GoemanJ, De DeynPP, EngelborghsS (2014) Behavioral syndromes in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis38, 319–329.
HollingworthP, HamshereML, MoskvinaV, DowzellK, MoorePJ, FoyC, ArcherN, LynchA, LovestoneS, BrayneC, RubinszteinDC, LawlorB, GillM, OwenMJ, WilliamsJ (2006) Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer’s disease. J Am Geriatr Soc54, 1348–1354.
14.
MirakhurA, CraigD, HartDJ, McLlroySP, PassmoreAP (2004) Behavioural and psychological syndromes in Alzheimer’s disease. Int J Geriatr Psychiatry19, 1035–1039.
15.
Heidler-GaryJ, GottesmanR, NewhartM, ChangS, KenL, HillisAE (2007) Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer’s disease. Dement Geriatr Cogn Disord23, 184–193.
16.
JessenF, AmariglioRE, van BoxtelM, BretelerM, CeccaldiM, ChetelatG, DuboisB, DufouilC, EllisKA, van der FlierWM, GlodzikL, van HartenAC, de LeonMJ, McHughP, MielkeMM, MolinuevoJL, MosconiL, OsorioRS, PerrotinA, PetersenRC, RabinLA, RamiL, ReisbergB, RentzDM, SachdevPS, de la SayetteV, SaykinAJ, ScheltensP, ShulmanMB, SlavinMJ, SperlingRA, StewartR, UspenskayaO, VellasB, VisserPJ, WagnerM, Subjective Cognitive Decline Initiative Working Group (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement10, 844–852.
17.
SwinkelsIC, KooijmanMK, SpreeuwenbergPM, BossenD, LeemrijseCJ, van DijkCE, VerheijR, de BakkerDH, VeenhofC (2014) An overview of 5 years of patient self-referral for physical therapy in the Netherlands. Phys Ther94, 1785–1795.
ArmstrongMJ, LitvanI, LangAE, BakTH, BhatiaKP, BorroniB, BoxerAL, DicksonDW, GrossmanM, HallettM, JosephsKA, KerteszA, LeeSE, MillerBL, ReichSG, RileyDE, TolosaE, TrosterAI, VidailhetM, WeinerWJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology80, 496–503.
20.
SeoSW, ImK, LeeJM, KimST, AhnHJ, GoSM, KimSH, NaDL (2011) Effects of demographic factors on cortical thickness in Alzheimer’s disease. Neurobiol Aging32, 200–209.
21.
KimJP, SeoSW, ShinHY, YeBS, YangJJ, KimC, KangM, JeonS, KimHJ, ChoH, KimJH, LeeJM, KimST, NaDL, GuallarE (2015) Effects of education on aging-related cortical thinning among cognitively normal individuals. Neurology85, 806–812.
22.
CollinsDL, NeelinP, PetersTM, EvansAC (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr18, 192–205.
23.
SledJG, ZijdenbosAP, EvansAC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging17, 87–97.
24.
ZijdenbosAP, ForghaniR, EvansAC (2002) Automatic “pipeline” analysis of 3-D MRI data for clinical trials: Application to multiple sclerosis. IEEE Trans Med Imaging21, 1280–1291.
25.
KimJS, SinghV, LeeJK, LerchJ, Ad-Dab’baghY, MacDonaldD, LeeJM, KimSI, EvansAC (2005) Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage27, 210–221.
26.
ImK, LeeJM, LeeJ, ShinYW, KimIY, KwonJS, KimSI (2006) Gender difference analysis of cortical thickness in healthy young adults with surface-based methods. Neuroimage31, 31–38.
27.
LytteltonO, BoucherM, RobbinsS, EvansA (2007) An unbiased iterative group registration template for cortical surface analysis. Neuroimage34, 1535–1544.
28.
RobbinsS, EvansAC, CollinsDL, WhitesidesS (2004) Tuning and comparing spatial normalization methods. Med Image Anal8, 311–323.
29.
AhnHJ, ChinJ, ParkA, LeeBH, SuhMK, SeoSW, NaDL (2010) Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci25, 1071–1076.
30.
KimH, NaDL (1999) Normative data on the Korean version of the Boston Naming Test. J Clin Exp Neuropsychol21, 127–133.
31.
Ku HMKJ, KwonEJ, KimSH, LeeHS, KoH (2004) A study on the reliability and validity of Seoul-Instrumental (S-IADL). J Korean Neuropsychiatr Assoc43, 10.
32.
MegaMS, CummingsJL, FiorelloT, GornbeinJ (1996) The spectrum of behavioral changes in Alzheimer’s disease. Neurology46, 130–135.
GenoveseCR, LazarNA, NicholsT (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage15, 870–878.
LyketsosCG, LopezO, JonesB, FitzpatrickAL, BreitnerJ, DeKoskyS (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA288, 1475–1483.
38.
MonasteroR, MangialascheF, CamardaC, ErcolaniS, CamardaR (2009) A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis18, 11–30.
39.
PetersME, RosenbergPB, SteinbergM, TschanzJT, NortonMC, Welsh-BohmerKA, HaydenKM, BreitnerJC, LyketsosCG, Cache County Investigators (2012) Prevalence of neuropsychiatric symptoms in CIND and its subtypes: The Cache County Study. Am J Geriatr Psychiatry20, 416–424.
40.
SheikhF, IsmailZ, MortbyME, BarberP, CieslakA, FischerK, GrangerR, HoganDB, MackieA, MaxwellCJ, MenonB, MuellerP, PatryD, PearsonD, QuickfallJ, SajobiT, TseE, WangM, SmithEE, PROMPT registry investigators (2017) Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr30, 233–244.
41.
DonovanNJ, HsuDC, DagleyAS, SchultzAP, AmariglioRE, MorminoEC, OkerekeOI, RentzDM, JohnsonKA, SperlingRA, MarshallGA (2015) Depressive symptoms and biomarkers of Alzheimer’s disease in cognitively normal older adults. J Alzheimers Dis46, 63–73.
MuangpaisanW, IntalapapornS, AssantachaiP (2008) Neuropsychiatric symptoms in the community-based patients with mild cognitive impairment and the influence of demographic factors. Int J Geriatr Psychiatry23, 699–703.
44.
Krell-RoeschJ, RuiderH, LoweVJ, StokinGB, PinkA, RobertsRO, MielkeMM, KnopmanDS, ChristiansonTJ, MachuldaMM, JackCR, PetersenRC, GedaYE (2016) FDG-PET and neuropsychiatric symptoms among cognitively normal elderly persons: The Mayo Clinic Study of Aging. J Alzheimers Dis53, 1609–1616.
45.
TaraganoFE, AllegriRF, KrupitzkiH, SarasolaDR, SerranoCM, LonL, LyketsosCG (2009) Mild behavioral impairment and risk of dementia: A prospective cohort study of 358 patients. J Clin Psychiatry70, 584–592.
46.
TaraganoFE, AllegriRF, LyketsosC (2008) Mild behavioral impairment: A prodromal stage of dementia. Dement Neuropsychol2, 256–260.
47.
LandesAM, SperrySD, StraussME (2005) Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci17, 342–349.
48.
MastersMC, MorrisJC, RoeCM (2015) “Noncognitive” symptoms of early Alzheimer disease: A longitudinal analysis. Neurology84, 617–622.
49.
SavvaGM, ZaccaiJ, MatthewsFE, DavidsonJE, McKeithI, BrayneC; Medical Research Council Cognitive Function and Ageing Study (2009) Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry194, 212–219.
50.
PerriR, MonacoM, FaddaL, CaltagironeC, CarlesimoGA (2014) Neuropsychological correlates of behavioral symptoms in Alzheimer’s disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: A comparative study. J Alzheimers Dis39, 669–677.
51.
YounJC, LeeDY, JhooJH, KimKW, ChooIH, WooJI (2011) Prevalence of neuropsychiatric syndromes in Alzheimer’s disease (AD). Arch Gerontol Geriatr52, 258–263.
52.
OssenkoppeleR, PijnenburgYA, PerryDC, Cohn-SheehyBI, ScheltensNM, VogelJW, KramerJH, van der VliesAE, La JoieR, RosenHJ, van der FlierWM, GrinbergLT, RozemullerAJ, HuangEJ, van BerckelBN, MillerBL, BarkhofF, JagustWJ, ScheltensP, SeeleyWW, RabinoviciGD (2015) The behavioural/dysexecutive variant of Alzheimer’s disease: Clinical, neuroimaging and pathological features. Brain138, 2732–2749.
53.
RaichleME, MacLeodAM, SnyderAZ, PowersWJ, GusnardDA, ShulmanGL (2001) A default mode of brain function. Proc Natl Acad Sci U S A98, 676–682.
BucknerRL, SnyderAZ, ShannonBJ, LaRossaG, SachsR, FotenosAF, ShelineYI, KlunkWE, MathisCA, MorrisJC, MintunMA (2005) Molecular, structural, and functional characterization of Alzheimer’s disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci25, 7709–7717.
56.
MendezMF (2012) Early-onset Alzheimer’s disease: Nonamnestic subtypes and type 2 AD. Arch Med Res43, 677–685.
57.
TaraganoFE, AllegriRF, HeiseckeSL, MartelliMI, FeldmanML, SanchezV, GarciaVA, TufroG, CastroDM, LeguizamonPP, GuelarV, RuotoloE, ZegarraC, DillonC (2018) Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. J Alzheimers Dis62, 227–238.
58.
GalynkerII, RoaneDM, MinerCR, FeinbergTE, WattsP (1995) Negative symptoms in patients with Alzheimer’s disease. Am J Geriatr Psychiatry3, 52–59.
59.
ReichmanWE, CoyneAC, AmirneniS, MolinoBJr., EganS (1996) Negative symptoms in Alzheimer’s disease. Am J Psychiatry153, 424–426.
60.
GalynkerII, DuttaE, VilkasN, OngsengF, FinestoneH, GallagherR, SerseniD, RosenthalRN (2000) Hypofrontality and negative symptoms in patients with dementia of Alzheimer type. Neuropsychiatry Neuropsychol Behav Neurol13, 53–59.
BellevilleS, ChertkowH, GauthierS (2007) Working memory and control of attention in persons with Alzheimer’s disease and mild cognitive impairment. Neuropsychology21, 458–469.
